Carregant...
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most frequent primary liver tumor. As a result of advanced disease being often present at diagnosis, only a small percentage of patients are amenable to curative-intent treatment options such as surgical resection and liver transplantation. Systemic therapy cons...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2022-04-01
|
| Col·lecció: | Cancers |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2072-6694/14/8/2018 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|